He and his team have also proposed a relationship between IL-33 and diseases such as sepsis (38), oncological chemotherapy (39), Alzheimer’s disease (40), and cerebral malaria (41, 42), and suggest that IL-33 is a double-edged sword, the rational regulation of which may have considerable potential therapeutic effects. The gene discussed is IL33; the disease is early-onset autosomal dominant Alzheimer disease.